News
The World Health Organization will recommend using weight-loss drugs to treat obesity in adults, according to draft guidance ...
MedPage Today on MSN
Higher-Dose Semaglutide Injection Proves Mettle in Phase III Trials
Tripling the weekly dose of semaglutide (Ozempic, Wegovy) resulted in greater weight loss compared with placebo in adults ...
Semaglutide is linked to significant weight loss and glucose levels in adults with schizophrenia, overweight/obesity, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results